EDGAR Filing Documents for 0001113423-17-000017

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001113423-17-000017

Filing Date

2017-05-08

Accepted

2017-05-08 17:18:54

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	q1-2017x6k.htm	6-K	19821
2	EXHIBIT 99.1	q1-2017xex991fsxquarterly.htm	EX-99.1	608153
3	EXHIBIT 99.2	q1-2017xex992mdaxquarterly.htm	EX-99.2	277699
4	EXHIBIT 99.3	q1-2017xex993certification.htm	EX-99.3	12591
5	EXHIBIT 99.4	q1-2017xex994certification.htm	EX-99.4	12642
6		aeternazentarislogoa29.jpg	GRAPHIC	14150
	Complete submission text file	0001113423-17-000017.txt		951696

Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1

Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211

Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 17823468
SIC: 2834 Pharmaceutical Preparations